Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function

NCT06194955
recruitingnot_applicable

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

NCT06934473
completednot_applicable

Physiology of GIP(1-30)NH2 in Humans

NCT04792762
completednot_applicable

GIP Receptor Antagonist Studies in Humans

NCT02747472

Clinical Trials (4)

Showing 4 of 4 trials
NCT06194955Not Applicable

The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function

Completed
NCT06934473Not Applicable

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

Recruiting
NCT04792762Not Applicable

Physiology of GIP(1-30)NH2 in Humans

Completed
NCT02747472Not Applicable

GIP Receptor Antagonist Studies in Humans

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4